Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
17
×
clinical trials
17
×
deals
17
×
life sciences
national blog main
san francisco blog main
17
×
boston blog main
san francisco top stories
boston top stories
fda
investing
national top stories
new york blog main
new york top stories
startups
indiana blog main
boulder/denver blog main
boulder/denver top stories
cancer
indiana top stories
national
raleigh-durham blog main
san diego blog main
seattle blog main
wisconsin blog main
wisconsin top stories
detroit blog main
detroit top stories
eli lilly
raleigh-durham top stories
san diego top stories
seattle top stories
texas blog main
texas top stories
boston
cancer immunotherapy
roche
takeda pharmaceutical
venture capital
abbvie
What
roundup
bio
drug
medicines
companies
ipo
biotech
cancer
days
fda
research
ahead
alliance
approval
approved
asco
cash
deal
developing
diabetes
digital
drugs
growing
hasn’t
help
key
led
life
million
nash
new
news
pact
patients
plans
raised
rnai
science
startup
street
Language
unset
Current search:
biotech
×
" san francisco blog main "
×
deals
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More